These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9164885

  • 1. Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.
    Am J Cardiol; 1997 May 01; 79(9):1198-202. PubMed ID: 9164885
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.
    Am Heart J; 2005 Jan 01; 149(1):112-20. PubMed ID: 15660042
    [Abstract] [Full Text] [Related]

  • 3. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr 01; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 4. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
    O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ, Philippon F, Sami M, Rocco TA, Padder FA, Champagne J, Pratt CM, Coutu B, Wyse DG, AFFIRM Investigators.
    Am J Cardiol; 2005 Sep 15; 96(6):815-21. PubMed ID: 16169368
    [Abstract] [Full Text] [Related]

  • 5. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, National Heart, Lung, and Blood Institute AFFIRM Investigators.
    Arch Intern Med; 2005 May 23; 165(10):1185-91. PubMed ID: 15911734
    [Abstract] [Full Text] [Related]

  • 6. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 23; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 7. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL.
    Circulation; 2004 Apr 27; 109(16):1973-80. PubMed ID: 15051639
    [Abstract] [Full Text] [Related]

  • 8. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
    Van Gelder IC, Van Veldhuisen DJ, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Bosker HA, Cornel JH, Kamp O, Veeger NJ, Volbeda M, Rienstra M, Ranchor AV, TenVergert EM, Van den Berg MP.
    Am Heart J; 2006 Sep 27; 152(3):420-6. PubMed ID: 16923407
    [Abstract] [Full Text] [Related]

  • 9. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG, AFFIRM Investigators.
    J Am Coll Cardiol; 2005 Nov 15; 46(10):1891-9. PubMed ID: 16286177
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 15; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct 15; 144(4):597-607. PubMed ID: 12360154
    [Abstract] [Full Text] [Related]

  • 12. Rate control versus rhythm control.
    Vidaillet H, Greenlee RT.
    Curr Opin Cardiol; 2005 Jan 15; 20(1):15-20. PubMed ID: 15596954
    [Abstract] [Full Text] [Related]

  • 13. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G, Prystowsky EN.
    Nat Clin Pract Cardiovasc Med; 2005 Oct 15; 2(10):514-21. PubMed ID: 16186849
    [Abstract] [Full Text] [Related]

  • 14. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
    Freudenberger RS, Wilson AC, Kostis JB, AFFIRM Investigators and Committees.
    Am J Cardiol; 2007 Jul 15; 100(2):247-52. PubMed ID: 17631079
    [Abstract] [Full Text] [Related]

  • 15. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL, Safford RE, AFFIRM trial, RACE trial.
    Card Electrophysiol Rev; 2003 Dec 15; 7(4):366-9. PubMed ID: 15071255
    [Abstract] [Full Text] [Related]

  • 16. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
    Cooper HA, Bloomfield DA, Bush DE, Katcher MS, Rawlins M, Sacco JD, Chandler M, AFFIRM Investigators.
    Am J Cardiol; 2004 May 15; 93(10):1247-53. PubMed ID: 15135698
    [Abstract] [Full Text] [Related]

  • 17. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
    Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL, Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1276-82. PubMed ID: 15364332
    [Abstract] [Full Text] [Related]

  • 18. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO, Marzouka GR, Rathod AD, Patel NJ, Myerburg RJ, Mitrani RD.
    Am J Cardiol; 2013 Jun 15; 111(12):1759-63. PubMed ID: 23540545
    [Abstract] [Full Text] [Related]

  • 19. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB, Seals AA, Safford RE, Slater W, Tullo NG, Vidaillet H, Wilber DJ, Slee A.
    Am Heart J; 2005 Feb 15; 149(2):304-8. PubMed ID: 15846269
    [Abstract] [Full Text] [Related]

  • 20. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO, Ellenbogen KA, Miller EH, Sherfesee L, Sheldon T, Whellan D.
    J Cardiovasc Electrophysiol; 2006 Dec 15; 17(12):1295-8. PubMed ID: 17081208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.